Dong — A Socio Holdings Subsidiary Wins KRW 13.5 Billion Drug Manufacturing Contract
Dong-A Socio Holdings' subsidiary signed a KRW 13.5 billion pharmaceutical contract manufacturing agreement with a global drugmaker. The contract represents 13% of the subsidiary's 2025 standalone revenue. Signed Oct. 16, 2026, the contract runs through June 30, 2027. * The agreement includes a KRW 1.88 billion advance